Riskpilot← Back to searchSign inGet full accessDEBIO MARKED AS
ASActiveOrg 915190715Bjørkeveien 20B, 1940 BjørkelangenOther education n.e.c. · NACE 8559Est. 201511 employees
Revenue 2024
NOK 12,5M
+4% vs 2023
EBITDA margin
5.9%
+46% vs 2023
Equity ratio
67.9%
Financial strength
Net profit 2024
NOK 707K
+39% vs 2023
| Revenue | NOK 12,5M | +4% |
| EBITDA | NOK 734K | +46% |
| Net profit | NOK 707K | +39% |
| Total assets | NOK 7,2M | +6% |
| Equity | NOK 4,9M | +17% |
| Employees | 11 | — |
Legal name
DEBIO MARKED AS
Org number
915190715
Legal form
Aksjeselskap
NACE code
8559 · Other education n.e.c.
Founded
14. april 2015
Share capital
NOK 100 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å fremme økologisk og bærekraftig produksjon, omsetning og forbruk.
Address
Bjørkeveien 20B, 1940 Bjørkelangen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 333 | 10 154 | 11 039 | 12 031 | 12 460 |
| Staff expenses | −4 952 | −5 197 | −7 119 | −8 115 | −8 080 |
| EBITDA | 577 | 1 433 | 66 | 503 | 734 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −34 |
| EBIT | 577 | 1 433 | 66 | 503 | 700 |
| Net financials | 1 | −0 | 1 | 5 | 6 |
| Profit before tax | 578 | 1 433 | 67 | 508 | 707 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 578 | 1 433 | 67 | 508 | 707 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 433 | 5 309 | 4 996 | 6 817 | 7 215 |
| Equity | 2 187 | 3 620 | 3 687 | 4 195 | 4 901 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 246 | 1 689 | 1 309 | 2 622 | 2 314 |
| Total debt | 1 246 | 1 689 | 1 309 | 2 622 | 2 314 |
EBITDA margin
5.9%
This company
15.8%
Market median
-63% vs market
20202024
Equity ratio
67.9%
This company
38.2%
Market median
+78% vs market
20202024
Return on equity
14.4%
This company
18.4%
Market median
+22% vs market
20202024
Net profit margin
5.7%
This company
8.1%
Market median
-30% vs market
20202024
Asset turnover
1.73×
This company
1.12×
Market median
+54% vs market
20202024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
OP Chief Executive Officer | Chief Executive Officer | 2017 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DEBIO MARKED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Henrik Kintzell Frøstrup | Chief Executive Officer | 0 companies |
| Ole Petter Fagerbæk Bernhus | Chief Executive Officer | 0 companies |
| Per Gunnar Skorge | Chairman | 0 companies |